PIKE Antibodies

Santa Cruz Biotechnology provides a broad selection of PIKE Antibodies for advanced research in cellular signaling and cancer biology. PIKE Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PIKE (Phosphatidylinositol 3-kinase enhancer) plays a crucial role in regulating cellular processes such as growth, survival, and migration by modulating the activity of phosphoinositide 3-kinase (PI3K). PIKE involvement in cancer progression and metastasis makes it a significant target for therapeutic research. Understanding PIKE function can provide insights into the mechanisms of tumorigenesis and aid in the development of novel cancer treatments. Researchers worldwide use PIKE monoclonal antibodies to investigate cellular pathways and molecular mechanisms in various biological systems. Current studies focus on how PIKE influences cell survival pathways and its potential as a therapeutic target in different cancer types. Ongoing research with PIKE monoclonal antibodies continues to reveal new aspects of cellular regulation and disease progression. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific knowledge and developing potential therapeutic strategies for cancer treatment.